Structure Therapeutics (GPCR) Operating Expenses (2022 - 2026)
Quarterly Operating Expenses rose 58.72% to $89.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $209.6 million through Mar 2026, up 14.85% year-over-year, with the annual reading at $176.6 million for FY2025, 11.59% up from the prior year.
Structure Therapeutics' Operating Expenses history spans 5 years, with the latest figure at $89.4 million for Q1 2026.
- Operating Expenses came in at $89.4 million for Q1 2026, up from -$24.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $89.4 million in Q1 2026 to a low of -$24.0 million in Q4 2025.
- The 5-year median for Operating Expenses is $31.0 million (2023), against an average of $34.1 million.
- Year-over-year, Operating Expenses soared 139.23% in 2023 and then tumbled 150.97% in 2025.
- Structure Therapeutics' Operating Expenses stood at $13.0 million in 2022, then skyrocketed by 139.23% to $31.0 million in 2023, then skyrocketed by 51.84% to $47.1 million in 2024, then tumbled by 150.97% to -$24.0 million in 2025, then surged by 472.58% to $89.4 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Operating Expenses are $89.4 million (Q1 2026), -$24.0 million (Q4 2025), and $73.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 89.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.38 Mn |
| Dec 31, 2025 | -23.99 Mn |
| Sep 30, 2025 | 73.79 Mn |
| Jun 30, 2025 | 70.45 Mn |
| Mar 31, 2025 | 56.31 Mn |
| Dec 31, 2024 | 47.06 Mn |
| Sep 30, 2024 | 45.84 Mn |
| Jun 30, 2024 | 33.32 Mn |
| Mar 31, 2024 | 32.02 Mn |
| Dec 31, 2023 | 30.99 Mn |
| Sep 30, 2023 | 26.15 Mn |
| Jun 30, 2023 | 25.99 Mn |
| Mar 31, 2023 | 19.65 Mn |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 12.69 Mn |
| Jun 30, 2022 | 13.96 Mn |
| Mar 31, 2022 | 12.95 Mn |